International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
Clinical trial NCT05096091 · COMPLETED
Trial details
- NCT number
- NCT05096091
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-16
- Primary completion
- 2025-08-19
- Enrollment
- 5399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.